58 related articles for article (PubMed ID: 27466033)
1. Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine-Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat.
Sunaga H; Savarese JJ; McGilvra JD; Heerdt PM; Belmont MR; Van Ornum SG; Murrell MT; Malhotra JK; Savard PM; Jeannotte E; Petty BJ; Allen E; Carnathan GW
Anesthesiology; 2016 Oct; 125(4):732-743. PubMed ID: 27466033
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine.
Savarese JJ; Sunaga H; McGilvra JD; Belmont MR; Murrell MT; Jeannotte E; Cooke FE; Wastila WB; Heerdt PM
Anesthesiology; 2018 Nov; 129(5):970-988. PubMed ID: 30212413
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs.
Heerdt PM; Malhotra JK; Pan BY; Sunaga H; Savarese JJ
Anesthesiology; 2010 Apr; 112(4):910-6. PubMed ID: 20234311
[TBL] [Abstract][Full Text] [Related]
4. Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology.
Sunaga H; Malhotra JK; Yoon E; Savarese JJ; Heerdt PM
Anesthesiology; 2010 Apr; 112(4):900-9. PubMed ID: 20234310
[TBL] [Abstract][Full Text] [Related]
5. Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.
Heerdt PM; Sunaga H; Owen JS; Murrell MT; Malhotra JK; Godfrey D; Steinkamp M; Savard P; Savarese JJ; Lien CA
Anesthesiology; 2016 Dec; 125(6):1136-1143. PubMed ID: 27749289
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.
Savarese JJ; Belmont MR; Hashim MA; Mook RA; Boros EE; Samano V; Patel SS; Feldman PL; Schultz JA; McNulty M; Spitzer T; Cohn DL; Morgan P; Wastila WB
Anesthesiology; 2004 Apr; 100(4):835-45. PubMed ID: 15087618
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action.
Gyermek L; Lee C; Cho YM; Nguyen N; Tsai SK
Anesth Analg; 2002 Apr; 94(4):879-85, table of contents. PubMed ID: 11916790
[TBL] [Abstract][Full Text] [Related]
9. Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.
Savarese JJ; McGilvra JD; Sunaga H; Belmont MR; Van Ornum SG; Savard PM; Heerdt PM
Anesthesiology; 2010 Jul; 113(1):58-73. PubMed ID: 20526187
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacodynamics of pancuronium, cisatracurium, and CW002 in rabbits.
Diaz LL; Zhang J; Heerdt PM
J Am Assoc Lab Anim Sci; 2014 May; 53(3):283-9. PubMed ID: 24827571
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of G-1-64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action.
Gyermek L; Lee C; Nguyen N
Acta Anaesthesiol Scand; 1999 Jul; 43(6):651-7. PubMed ID: 10408820
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers.
Kaullen JD; Owen JS; Brouwer KLR; Heerdt PM; Lien CA; Savarese JJ; Schmith VD
Anesthesiology; 2018 Jun; 128(6):1107-1116. PubMed ID: 29494403
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey.
Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH
Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358
[TBL] [Abstract][Full Text] [Related]
14. The autonomic margins of safety of metocurine and d-tubocurarine in the cat.
Savarese JJ
Anesthesiology; 1979 Jan; 50(1):40-6. PubMed ID: 83803
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.
Boros EE; Samano V; Ray JA; Thompson JB; Jung DK; Kaldor I; Koble CS; Martin MT; Styles VL; Mook RA; Feldman PL; Savarese JJ; Belmont MR; Bigham EC; Boswell GE; Hashim MA; Patel SS; Wisowaty JC; Bowers GD; Moseley CL; Walsh JS; Reese MJ; Rutkowske RD; Sefler AM; Spitzer TD
J Med Chem; 2003 Jun; 46(12):2502-15. PubMed ID: 12773054
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs.
Heerdt PM; Kang R; The' A; Hashim M; Mook RJ; Savarese JJ
Anesthesiology; 2004 Apr; 100(4):846-51. PubMed ID: 15087619
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients.
Goldberg ME; Larijani GE; Azad SS; Sosis M; Seltzer JL; Ascher J; Weakly JN
Anesth Analg; 1989 Jul; 69(1):93-9. PubMed ID: 2525886
[TBL] [Abstract][Full Text] [Related]
18. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
19. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
Schwarz S; Agoston S; Houwertjes MC
Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of vecuronium in adolescents and children.
Goudsouzian NG; Martyn JJ; Liu LM; Gionfriddo M
Anesth Analg; 1983 Dec; 62(12):1083-8. PubMed ID: 6139963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
